awmsg logo



prucalopride (Resolor®)


Reference No. 918

Publication date:
06/04/2016


Appraisal information

prucalopride (Resolor®) 1 mg film-coated tablet
prucalopride (Resolor®) 2 mg film-coated tablet


Company: Shire Pharmaceuticals Ltd
BNF category: Gastro-intestinal system
NMG meeting date: 10/02/2016
AWMSG meeting date: 23/03/2016
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 0816
Ministerial ratification: 05/04/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Prucalopride (Resolor®) is recommended as an option for use within NHS Wales for the treatment of chronic constipation in men in whom laxatives fail to provide adequate relief.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download